What Public Information Usually Appears Before an FDA Decision?
When people first follow biotech, they often imagine an FDA decision as a silent process that ends with a single approval or rejection headline. In reality, the period before an FDA outcome often contains a series of smaller public signals. Some are formal regulatory milestones. Others are indirect clues that help investors and operators understand where the review may be heading.